305 related articles for article (PubMed ID: 27191269)
21. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.
Kim JS; Shin DH; Kim JS
J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480
[TBL] [Abstract][Full Text] [Related]
22. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
23. Binding and distribution of Na2B12H11SH on cellular and subcellular level in tumor tissue of glioma patients in boron neutron capture therapy.
Otersen B; Haritz D; Grochulla F; Bergmann M; Sierralta W; Gabel D
J Neurooncol; 1997 May; 33(1-2):131-9. PubMed ID: 9151230
[TBL] [Abstract][Full Text] [Related]
24. Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers.
Koganei H; Ueno M; Tachikawa S; Tasaki L; Ban HS; Suzuki M; Shiraishi K; Kawano K; Yokoyama M; Maitani Y; Ono K; Nakamura H
Bioconjug Chem; 2013 Jan; 24(1):124-32. PubMed ID: 23214414
[TBL] [Abstract][Full Text] [Related]
25. Boron Neutron Capture Therapy of Malignant Gliomas.
Miyatake SI; Kawabata S; Hiramatsu R; Kuroiwa T; Suzuki M; Ono K
Prog Neurol Surg; 2018; 32():48-56. PubMed ID: 29990973
[TBL] [Abstract][Full Text] [Related]
26. Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo--a new possibility in boron neutron capture therapy.
Ceberg CP; Brun A; Mir LM; Persson BR; Salford LG
Anticancer Drugs; 1994 Aug; 5(4):463-6. PubMed ID: 7949252
[TBL] [Abstract][Full Text] [Related]
27. Pretreatment with buthionine sulfoximine enhanced uptake and retention of BSH in brain tumor.
Yoshida F; Yamamoto T; Nakai K; Zaboronok A; Matsuda M; Akutsu H; Ishikawa E; Shirakawa M; Matsumura A
Appl Radiat Isot; 2014 Jun; 88():86-8. PubMed ID: 24731546
[TBL] [Abstract][Full Text] [Related]
28. Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His.
Feng B; Tomizawa K; Michiue H; Miyatake S; Han XJ; Fujimura A; Seno M; Kirihata M; Matsui H
Biomaterials; 2009 Mar; 30(9):1746-55. PubMed ID: 19121537
[TBL] [Abstract][Full Text] [Related]
29. Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma.
Haselsberger K; Radner H; Pendl G
Neurosurgery; 1996 Aug; 39(2):321-5; discussion 325-6. PubMed ID: 8832669
[TBL] [Abstract][Full Text] [Related]
30. Silencing of ATM expression by siRNA technique contributes to glioma stem cell radiosensitivity in vitro and in vivo.
Li Y; Li L; Wu Z; Wang L; Wu Y; Li D; Ma U; Shao J; Yu H; Wang D
Oncol Rep; 2017 Jul; 38(1):325-335. PubMed ID: 28560406
[TBL] [Abstract][Full Text] [Related]
31. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
Chang CH; Liu WT; Hung HC; Gean CY; Tsai HM; Su CL; Gean PW
BMC Cancer; 2017 Dec; 17(1):905. PubMed ID: 29284440
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of sodium borocaptate: a critical assessment of dosing paradigms for boron neutron capture therapy.
Gibson CR; Staubus AE; Barth RF; Yang W; Ferketich AK; Moeschberger MM
J Neurooncol; 2003; 62(1-2):157-69. PubMed ID: 12749711
[TBL] [Abstract][Full Text] [Related]
33. Combined use of sodium borocaptate and buthionine sulfoximine in boron neutron capture therapy enhanced tissue boron uptake and delayed tumor growth in a rat subcutaneous tumor model.
Yoshida F; Yamamoto T; Nakai K; Kumada H; Shibata Y; Tsuruta W; Endo K; Tsurubuchi T; Matsumura A
Cancer Lett; 2008 May; 263(2):253-8. PubMed ID: 18272285
[TBL] [Abstract][Full Text] [Related]
34. Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.
Wu G; Yang W; Barth RF; Kawabata S; Swindall M; Bandyopadhyaya AK; Tjarks W; Khorsandi B; Blue TE; Ferketich AK; Yang M; Christoforidis GA; Sferra TJ; Binns PJ; Riley KJ; Ciesielski MJ; Fenstermaker RA
Clin Cancer Res; 2007 Feb; 13(4):1260-8. PubMed ID: 17317838
[TBL] [Abstract][Full Text] [Related]
35. Self-assembling A6K peptide nanotubes as a mercaptoundecahydrododecaborate (BSH) delivery system for boron neutron capture therapy (BNCT).
Michiue H; Kitamatsu M; Fukunaga A; Tsuboi N; Fujimura A; Matsushita H; Igawa K; Kasai T; Kondo N; Matsui H; Furuya S
J Control Release; 2021 Feb; 330():788-796. PubMed ID: 33188824
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
[TBL] [Abstract][Full Text] [Related]
37. Optimization of preparation methods for high loading content and high encapsulation efficiency of BSH into liposomes.
Shirakawa M; Nakai K; Sato Y; Nakamura S; Harada M; Ishihara K; Yoshida F; Matsumura A; Tomida H
Appl Radiat Isot; 2021 Mar; 169():109260. PubMed ID: 33160809
[TBL] [Abstract][Full Text] [Related]
38. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).
Haritz D; Gabel D; Huiskamp R
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1175-81. PubMed ID: 8175403
[TBL] [Abstract][Full Text] [Related]
39. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
[TBL] [Abstract][Full Text] [Related]
40. Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH).
Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
Jpn J Cancer Res; 1998 Dec; 89(12):1352-7. PubMed ID: 10081497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
